References
- SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin2017671 7 3028055103
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin2016662 115 13226808342
- SaltzmanWMFungLKPolymeric implants for cancer chemotherapyAdv Drug Deliv Rev1997262–3 209 23010837544
- GoldbergEPHadbaARAlmondBAMarottaJSIntratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug deliveryJ Pharm Pharmacol2002542 159 18011848280
- WeinbergBDBlancoEGaoJPolymer implants for intratumoral drug delivery and cancer therapyJ Pharm Sci2008975 1681 170217847077
- Hohenforst-SchmidtWZarogoulidisPDarwicheKIntratumoral chemotherapy for lung cancer: re-challenge current targeted therapiesDrug Des Devel Ther20137 571 583
- WolinskyJBColsonYLGrinstaffMWLocal drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafersJ Control Release20121591 14 2622154931
- AbolmaaliSSTamaddonAMDinarvandRA review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritisCancer Chemother Pharmacol2013715 1115 113023292116
- Pereira AdeFPereiraLGBarbosaLAEfficacy of methotrexate-loaded poly(epsilon-caprolactone) implants in Ehrlich solid tumor-bearing miceDrug Deliv2013203–4 168 17923738591
- GenestierLPaillotRQuemeneurLIzeradjeneKRevillardJPMechanisms of action of methotrexateImmunopharmacology2000472–3 247 25710878292
- MisraRMohantySSustained release of methotrexate through liquid-crystalline folate nanoparticlesJ Mater Sci Mater Med2014259 2095 210924952639
- GaiesEJebabliNMethotrexate Side Effects: Review ArticleJ Drug Metab Toxicol201234 1 5
- Al-QuteimatOMAl-BadainehMAPractical issues with high dose methotrexate therapySaudi Pharm J2014224 385 38725161385
- SinghUVPandeySUmadeviPUdupaNPreparation, characterization, and antitumor efficacy of biodegradable poly(lactic acid) methotrexate implantable filmsDrug Delivery199742 101 106
- KapoorDNBhatiaAKaurRSharmaRKaurGDhawanSPLGA: a unique polymer for drug deliveryTher Deliv201561 41 5825565440
- The State Pharmacopoeia Commission of People’s Republic of ChinaThe Pharmacopoeia of the People’s Republic of ChinaBeijing: ChinaMedical Science Press2015
- GaoLXieCDuYCharacterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implantsDrug Deliv2017241 765 77428475414
- DongYChinSFBlancoEIntratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapyClin Cancer Res2009151 131 13919118040
- DongWZhangLNiuYA stable and practical etoposide-containing intravenous long-/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacyExpert Opin Drug Deliv2013105 559 57123373755
- MitchellDACuiXSchmittlingRJMonoclonal antibody blockade of IL-2 receptor alpha during lymphopenia selectively depletes regulatory T cells in mice and humansBlood201111811 3003 301221768296
- AyyappanSSundaraganesanNAroulmojiVMuranoESebastianSMolecular structure, vibrational spectra and DFT molecular orbital calculations (TD-DFT and NMR) of the antiproliferative drug MethotrexateSpectrochim Acta A Mol Biomol Spectrosc2010771 264 27520621610
- GharebaghiFDalaliNAhmadiEDanafarHPreparation of wormlike polymeric nanoparticles coated with silica for delivery of methotrexate and evaluation of anticancer activity against MCF7 cellsJ Biomater Appl2017319 1305 131628447548
- de Fatima PereiraAMara da CostaVCristina Magalhaes SantosMEvaluation of the effects of methotrexate released from polymeric implants in solid Ehrlich tumorBiomed Pharmacother2014683 365 36824529847
- XuYKimCSSaylorDMKooDPolymer degradation and drug delivery in PLGA-based drug-polymer applications: a review of experiments and theoriesJ Biomed Mater Res B Appl Biomater20171056 1692 171627098357
- El-BadryMFetihGFathyMImprovement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000Saudi Pharm J2009173 217 22523964164
- ChengLLeiLGuoSIn vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blendsInt J Pharm20103871–2 129 13820005928
- WangKZhangXZhangLDevelopment of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral releaseDrug Deliv2015223 389 39924670095
- SolanoAGde Fatima PereiraAPintoFCDevelopment and evaluation of sustained-release etoposide-loaded poly(epsilon-caprolactone) implantsAAPS PharmSciTech2013142 890 90023666789
- ChadhaRAroraPKaurRSainiASinglaMLJainDSCharacterization of solvatomorphs of methotrexate using thermoanalytical and other techniquesActa Pharm2009593 245 25719819822
- LiCChengLZhangYGuoSWuWEffects of implant diameter, drug loading and end-capping on praziquantel release from PCL implantsInt J Pharm20103861–2 23 2919895876
- WongPTChoiSKMechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic deliveryInt J Mol Sci2015161 1772 179025590303
- RotmanMRosenthalCJConcomitant Continuous Infusion Chemotherapy and Radiation1st edBerlin HeidelbergSpringer-verlag1991